GlassScriptPhysician profile
Jeffrey Foster
NPI 1376957498
$56,360.11
in general payments reported to CMS, 2019-2025
39 companies · $3,379 in 2025
The $3,379 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,947 · 2020: $5,484 · 2021: $15K · 2022: $8,768 · 2023: $13K · 2024: $5,663 · 2025: $3,379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $4,111 · Consulting Fee: $2,125 · Entertainment: $73.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,205.52 |
| Travel and Lodging | $4,110.72 |
| Consulting Fee | $2,125.00 |
| Entertainment | $73.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $13,954.08 | 2019-2024 | Senza |
| Abbott Laboratories | $13,308.80 | 2019-2025 | Proclaim, Eterna, Infinity |
| Nalu Medical, INC. | $8,544.24 | 2020-2024 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $5,752.36 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Omnia Medical, LLC | $5,500.00 | 2021-2022 | |
| Spinal Simplicity, LLC | $1,605.54 | 2020-2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $1,442.85 | 2023-2025 | Evoke, Evoke Scs |
| Relievant Medsystems, INC. | $819.94 | 2019-2023 | Intracept |
| Globus Medical, INC. | $705.27 | 2025 | Senza |
| Vertos Medical, INC. | $672.97 | 2019 | |
| Spr Therapeutics, INC | $634.80 | 2019-2025 | Sprint Pns System |
| Medtronic, INC. | $615.93 | 2021-2023 | Intellis Adaptivestim, Simulus |
| Painteq LLC | $582.43 | 2022-2024 | Painteq |
| Foundation Fusion Solutions, LLC | $559.20 | 2023-2024 | |
| Biotronik Nro, INC. | $268.63 | 2024-2025 | Prospera |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $254.93 | 2023-2024 | |
| Flowonix Medical Incorporated | $233.89 | 2020 | |
| Averitas Pharma INC. | $177.30 | 2023-2025 | Qutenza |
| Medtronic USA, INC. | $124.84 | 2019-2020 | |
| Mml US, INC. | $103.94 | 2024 | Reactiv8 |
| Vertex Pharmaceuticals Incorporated | $53.28 | 2025 | |
| Vertiflex, INC. | $46.67 | 2019 | |
| Genzyme Corporation | $44.69 | 2024-2025 | |
| Innovation Technologies INC | $37.02 | 2023 | Irrisept |
| Abbvie INC. | $35.49 | 2023 | |
| Titan Surgical Group, LLC | $31.11 | 2024 | |
| Melinta Therapeutics, LLC | $29.31 | 2024-2025 | Kimyrsa, Rezzayo |
| Stryker Corporation | $28.39 | 2020 | |
| Mallinckrodt Hospital Products INC. | $26.30 | 2023 | Acthar |
| Jazz Pharmaceuticals INC. | $21.10 | 2025 | |
| Ossur Americas, INC. | $17.70 | 2024 | Miami J |
| Baxter Healthcare | $17.63 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Merit Medical Systems INC | $17.26 | 2021 | |
| Bioventus LLC | $16.88 | 2025 | Xcell |
| Astrazeneca Pharmaceuticals LP | $16.80 | 2025 | Fasenra |
| Merck Sharp & Dohme LLC | $15.43 | 2023 | |
| Grifols USA, LLC | $14.81 | 2024 | Prolastin-C Liquid |
| Convatec INC. | $14.41 | 2024 | |
| Paratek Pharmaceuticals, INC. | $13.89 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.